IL6 is frequently upregulated in GBM, where it activates JAK/STAT3 signaling to promote tumor cell survival, proliferation, and therapy resistance, and contributes to an immunosuppressive milieu (West et al., 2018). The gene discussed is IL6; the disease is neoplasm.